| Literature DB >> 35481303 |
Khalid G Almramhi1, Moussa A Alkhateeb1, Omar A Alsulami1, Saeed A Alhudaifi1, Hamza Alamoudi1, Rana A Nabalawi2.
Abstract
Background Acute kidney injury (AKI) is a syndrome that has been receiving considerable attention as a common risk in cardiac surgeries, which has consequences for short- and long-term survival implications, even for those who do not progress to renal failure. There have been limited studies in the Middle East, and specifically in the Kingdom of Saudi Arabia (KSA). Therefore, our study aimed to identify the prevalence of and risk factors for AKIs following adult cardiac interventions during 2010-2020 at the King Abdulaziz University Hospital (KAUH), Jeddah, Saudi Arabia. Methods Setting and Design: A retrospective medical record review was conducted among all the adult patients who underwent cardiac interventions and developed AKIs between 2010 and 2020. Google forms were used to extract the data from the hospital records. About statistical analysis binary logistic regression analyses, relative risks (RRs), and confidence intervals (CI) were used to determine the associations among the variables. Results After applying the inclusion and exclusion criteria, 564 patients were included. Their baseline demographic, clinical, biological, and operative characteristics were analyzed. AKIs developed in 110 (19.5%) patients and patients with diabetes were more likely to develop AKIs (P < 0.012, RR = 2.280, CI = 1.198-4.339). Hypertension showed a strong effect in the development of AKIs (P < 0.004, RR = 2.865, CI = 1.391-5.900). Moreover, patients who suffered from chronic heart failure were more prone to the development of AKIs (P < 0.008, RR = 4.189, CI =1.452-12.087). Furthermore, anemia with significant P-values (<0.002), and CIs of 1.509-6.822, indicated that these patients were more likely to develop AKIs (3.209 times). Conclusion We demonstrated that AKIs are frequent complications in adults after cardiac interventions and were associated with poor outcomes. Risk factors for the development of AKIs were identified to be diabetes mellitus, hypertension, chronic heart failure, and anemia. Further investigation of this cohort is necessary to better understand the problem of kidney injuries.Entities:
Keywords: acute kidney injury; cardiac interventions; comorbidities; prevalence; risk factors
Year: 2022 PMID: 35481303 PMCID: PMC9033530 DOI: 10.7759/cureus.23387
Source DB: PubMed Journal: Cureus ISSN: 2168-8184
Demographic and Descriptive Characteristic of Patients
CABG: coronary artery bypass graft surgery; PTCA: percutaneous transluminal coronary angioplasty; LVEF: left ventricular ejection fraction; LOH: length of hospitality; BMI: body mass index
| Variable | Total Number: N = 564 (100%) | Develop AKI: N = 110 (19.5%) | Non-develop AKI: N = 454 (80.5%) |
| Gender(1): Male | 481 (85.3%) | 81 (73.6%) | 400 (88.1%) |
| gender(2): Female | 83 (14.7%) | 29 (26.4%) | 54 (11.9%) |
| Nationality(1): Saudi | 87 (15.5%) | 21 (19.4%) | 66 (14.6%) |
| Nationality(2): Non-Saudi | 473 (84.5%) | 87 (80.6%) | 386 (85.4%) |
| Priority of surgery(1): Elective | 492 (87.2%) | 81 (73.6%) | 411 (90.5%) |
| Priority of surgery (2): emergency | 72 (12.8%) | 29 (26.4%) | 43 (9.5%) |
| Type of surgery(1): CABG | 407 (72.2%) | 100 (90.9%) | 307 (67.6%) |
| Type of surgery(2): PTCA | 157 (27.8%) | 10 (9.1%) | 149 (32.4%) |
| Descriptive | All (Mean±SD) | Develop AKI (Mean±SD) | Non-develop AKI (Mean±SD) |
| Age (years) | 61.64±9.97 | 63.05±10.036 | 61.30±9.943 |
| LVEF (%) | 47.11±12.36 | 43±11.715 | 48.078±12.327 |
| Surgery duration (min) | 269.46±58.50 | 276.87±61.083 | 267.04±57.540 |
| LOH (day) | 6.11±6.31 | 9.41±9.477 | 5.36±5.068 |
| BMI (kg/m2) | 27.43±43.43 | 27.57±4.56 | 27.40±4.40 |
Figure 1Frequency of Risk Factors among All the Patients Included in the Study
HTN: hypertension; DM: diabetes mellitus; IHD: ischemic heart disease; CKD: chronic kidney disease; CHF: chronic heart failure; CVD: cardiovascular disease; PVD: peripheral vascular disease
Multivariate Analysis of Preoperative Risk Factors Associated with AKI
RR: relative risk; CI: confidence intervals; CLD: chronic liver disease; PVD: peripheral vascular disease; CKD: chronic kidney disease; CABG: coronary artery bypass graft surgery; PTCA: percutaneous transluminal coronary angioplasty; LVEF: left ventricular ejection fraction; LOH: length of hospitalization; BMI: body mass index. All Variables were analyzed by binary logistic regression test. Age, LVEF, LOH, BMI, and surgery duration were described by mean and SD, others by number and percentage.
| Variable | Total number (N = 564) | Develop AKI (N = 110) | Non-develop AKI (N = 454) | P-value | RR | 95% CI (lower-upper) |
| Gender(1): male | 481 (85.3%) | 81 (73.6%) | 400 (88.1%) | <0.008 | 0.440 | (0.240-0.807) |
| Gender(2): Female | 83 (14.7%) | 29 (26.4%) | 54 (11.9%) | <0.008 | 2.005 | (1.135-3.542) |
| Nationality(1): Saudi | 87 (15.5%) | 21 (19.4%) | 66 (14.6%) | <0.242 | 1.462 | (0.773-2.766) |
| Nationality(2): Non-Saudi | 473 (84.5%) | 87 (80.6%) | 386 (85.4%) | <0.242 | 0.684 | ( 0.362-1.293 ) |
| Risk Factors | Total number (N = 564) | Develop AKI (N = 110) | Non-develop AKI (N = 454) | P-value | RR | 95% CI (Lower-Upper) |
| Diabetes mellitus | 392 (69.5%) | 94 (85.5%) | 298 (65.5%) | <0.012 | 2.280 | (1.198-4.339 ) |
| Hypertension | 409 (72.5%) | 98 (89.1%) | 311 (68.5%) | <0.004 | 2.865 | (1.391-5.900) |
| Ischemic heart disease | 392 (69.5%) | 78 (70.9%) | 314 (69.2%) | <0.623 | 0.875 | (0.512-1.493) |
| Chronic heart failure | 26 (4.6%) | 11 (10%) | 15 (3.3%) | <0.008 | 4.189 | (1.452-12.087) |
| Malignancy | 13 (2.3%) | 0 (0%) | 13(2.9%) | <0.999 | 0.000 | |
| Cerebrovascular disease | 19 (3.4%) | 5 (4.5%) | 14 (3.1%) | <0.381 | 1.812 | (0.479-6.856) |
| Autoimmune disease | 5 (0.9%) | 0 (0%) | 5 (1.1%) | <0.999 | 0.000 | |
| Thyroid disease | 10 (1.8%) | 1 (0.9%) | 9 (2%) | <0.555 | 0.458 | (0.034-6.106) |
| CLD | 5 (0.9%) | 0 (0%) | 5 (1.1%) | <1.000 | 0.573 | |
| PVD | 10 (1.8%) | 1 (0.9%) | 9 (2%) | <0.279 | 0.276 | (0.027-2.842) |
| Respiratory disease | 23 (4.1%) | 3 (2.7%) | 20(4.4%) | <0.258 | 0.435 | (0.103-1.839) |
| CKD | 28 (5%) | 13 (11.8%) | 15 (3.3%) | <0.016 | 3.373 | (1.250-9.098) |
| Anemia | 54 (9.6%) | 18 (16.4%) | 36 (7.9%) | <0.002 | 3.209 | (1.509-6.822) |
| Hyperlipidemia | 84 (14.9%) | 17 (15.5%) | 67 (14.8%) | <0.881 | 0.949 | (0.480-1.878) |
| Obesity | 116 (20.6%) | 22 (20%) | 94 (20.7%) | <0.616 | 0.850 | (0.451-1.604) |
| Liver cirrhosis | 5 (0.9%) | 0 (0%) | 5 (1.1%) | <0.999 | 0.000 | |
| type of surgery(1): CABG | 407 (72.2%) | 100 (90.9%) | 307 (67.6%) | <0.000 | 4.909 | (2.271-10.612) |
| type of surgery(2): PTCA | 157 (27.8%) | 10 (9.1%) | 149 (32.4) | <0.000 | 0.204 | (0.094-0.440) |
| priority of surgery(1): Elective | 492 (87.2%) | 81 (73.6%) | 411 (90.5%) | <0.002 | 0.372 | (0.198-0.699) |
| priority of surgery(2): Emergency | 72 (12.8%) | 29 (26.4%) | 43 (9.5%) | <0.002 | 2.687 | (1.431-5.046) |
| Age (years) | 61.64±9.97 | 63.05±10.036 | 61.30±9.943 | <0.632 | 0.0994 | (0.968-1.020) |
| LVEF (%) | 47.11±12.36 | 43±11.715 | 48.078±12.327 | <0.000 | 1.041 | (1.018-1.064) |
| LOH (Days) | 6.11±6.31 | 9.41±9.477 | 5.36±5.068 | <0.005 | 0.943 | (0.905-0.982) |
| BMI (kg/m2) | 27.43±43.43 | 27.57±4.56 | 27.40±4.40 | <0.475 | 0.970 | (0.0891-1.055) |
| Surgery duration (min) | 269.46±58.50 | 276.87±61.083 | 267.04±57.540 | <0.109 | 0.996 | (0.992-1.001) |
Multivariate Analysis of Pre- and Postoperative Laboratory Results Associated with AKI
Data presented as: mean ± standard deviation; P-value; RR: relative risk; CI: confidence intervals. Hb: hemoglobin; BUN: blood urea nitrogen; HCT: hematocrit
| Variable | Total Number (N = 564) | Develop AKI (N = 110) | Non-develop AKI (N = 454) | P-value | RR | 95% CI (Lower-Upper) |
| Preoperative creatinine | 96.47±44.98 | 119.399±74.45 | 90.89±31.91 | <0.000 | 1.183 | (1.116-1.255) |
| Postoperative creatinine | 143.67±105.40 | 277.92±153.51 | 107.92±41.84 | <0.000 | 0.860 | (0.820-0.902) |
| Preoperative Hb | 13.09±2.05 | 12.28±2.26 | 13.29±1.95 | <0.779 | 0.827 | (0.219-3.121) |
| Preoperative BUN | 5.97±3.29 | 7.65±4.46 | 5.57±2.81 | <0.648 | 0.932 | (0.690-1.260) |
| Preoperative HCT | 39.28±5.69 | 37.33±6.92 | 39.74±5.46 | <0.932 | 0.979 | (0.605-1.584) |